Iran Keeps Strait of Hormuz Closed to Deter Israeli Strikes on Lebanon Allies
Iran announced it will stop exchanging messages with the U.S. through intermediaries and keep the Strait of Hormuz closed. The decision follows accusations of ceasefire violations tied to military operations in Lebanon.
The HillIran has halted ceasefire talks with the U.S. and will keep the Strait of Hormuz closed, according to a report from Iran’s state-affiliated outlet Tasnim News Agency. The report, translated from a post on the messaging app Telegram, accused the Trump administration of ceasefire violations and pointed to military operations in Lebanon as the trigger.
Rubio said the first condition for any Iran talks is that Iran opens the Strait of Hormuz. Rubio added that Iran must announce very clearly that the Hormuz Strait is now open. He also said Iran must commit to specific negotiations on the disposition of highly enriched uranium.
Iran’s state-affiliated outlet Tasnim News Agency reported that the country will stop exchanging messages with the U.S. through intermediaries. The same report said Iran will move to close the Strait of Hormuz. " The developments leave the status of any future talks uncertain.
Transparency
Story details
Related Stories
U.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect
A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.
prnewswire.comFed Chairman Names Two Outside Advisers During Transition
Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.
insidermonkey.comForte Biosciences Accepts Resignation of Director David Veitch
Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…